Your browser doesn't support javascript.
loading
Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells.
Malleret, Benoît; El Sahili, Abbas; Tay, Matthew Zirui; Carissimo, Guillaume; Ong, Alice Soh Meoy; Novera, Wisna; Lin, Jianqing; Suwanarusk, Rossarin; Kosaisavee, Varakorn; Chu, Trang T T; Sinha, Ameya; Howland, Shanshan Wu; Fan, Yiping; Gruszczyk, Jakub; Tham, Wai-Hong; Colin, Yves; Maurer-Stroh, Sebastian; Snounou, Georges; Ng, Lisa F P; Chan, Jerry Kok Yen; Chacko, Ann-Marie; Lescar, Julien; Chandramohanadas, Rajesh; Nosten, François; Russell, Bruce; Rénia, Laurent.
Affiliation
  • Malleret B; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. Benoit_Malleret@nus.edu.sg.
  • El Sahili A; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Benoit_Malleret@nus.edu.sg.
  • Tay MZ; Immunology Translational Research Programme, Yong Loo Lin School of Medicine, Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore. Benoit_Malleret@nus.edu.sg.
  • Carissimo G; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
  • Ong ASM; NTU Institute for Structural Biology, Nanyang Technological University, Singapore, Singapore.
  • Novera W; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Lin J; A*STAR ID Labs, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Suwanarusk R; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Kosaisavee V; A*STAR ID Labs, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Chu TTT; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Sinha A; A*STAR ID Labs, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Howland SW; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Fan Y; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
  • Gruszczyk J; A*STAR ID Labs, Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Tham WH; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Colin Y; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Maurer-Stroh S; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Snounou G; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Ng LFP; Department of Parasitology and Entomology, Faculty of Public Health, Mahidol University, Bangkok, Thailand.
  • Chan JKY; Pillar of Engineering Product Development, Singapore University of Technology & Design, Singapore, Singapore.
  • Chacko AM; Pillar of Engineering Product Development, Singapore University of Technology & Design, Singapore, Singapore.
  • Lescar J; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
  • Chandramohanadas R; Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore.
  • Nosten F; Experimental Fetal Medicine Group, Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Russell B; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Rénia L; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Nat Microbiol ; 6(8): 991-999, 2021 08.
Article in En | MEDLINE | ID: mdl-34294905
ABSTRACT
More than one-third of the world's population is exposed to Plasmodium vivax malaria, mainly in Asia1. P. vivax preferentially invades reticulocytes (immature red blood cells)2-4. Previous work has identified 11 parasite proteins involved in reticulocyte invasion, including erythrocyte binding protein 2 (ref. 5) and the reticulocyte-binding proteins (PvRBPs)6-10. PvRBP2b binds to the transferrin receptor CD71 (ref. 11), which is selectively expressed on immature reticulocytes12. Here, we identified CD98 heavy chain (CD98), a heteromeric amino acid transporter from the SLC3 family (also known as SLCA2), as a reticulocyte-specific receptor for the PvRBP2a parasite ligand using mass spectrometry, flow cytometry, biochemical and parasite invasion assays. We characterized the expression level of CD98 at the surface of immature reticulocytes (CD71+) and identified an interaction between CD98 and PvRBP2a expressed at the merozoite surface. Our results identify CD98 as an additional host membrane protein, besides CD71, that is directly associated with P. vivax reticulocyte tropism. These findings highlight the potential of using PvRBP2a as a vaccine target against P. vivax malaria.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Plasmodium vivax / Malaria, Vivax / Fusion Regulatory Protein 1, Heavy Chain / Erythrocytes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Microbiol Year: 2021 Type: Article Affiliation country: Singapore

Full text: 1 Database: MEDLINE Main subject: Plasmodium vivax / Malaria, Vivax / Fusion Regulatory Protein 1, Heavy Chain / Erythrocytes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Microbiol Year: 2021 Type: Article Affiliation country: Singapore